In addition to cell cycle regulation via p21 and p27, SKP2 is known to promote epithelial–mesenchymal transition (EMT), EMT-related stemness properties, and drug resistance in cancer cells by ubiquitinating various substrates [29–36]. This evidence concerns the gene SKP2 and cancer.